The New American Entrepreneur – Euclises

The New American Entrepreneur – Euclises

Euclises is drug discovery and development company targeting some of the deadliest cancers out there—cancers that combine to cause over 200,000 fatalities each year in the U.S. alone. By offering new treatment options for cancer patients suffering from colorectal,... Read more

Evidence Based Innovation 1.0 – Recap

An Event to Connect Investors with Health Care Startups While early-stage startup companies talk a lot about investment, the one thing every young company needs is a customer. Last Tuesday, more than 20 early-stage St. Louis medical and biotech companies got the... Read more

A Q&A session with Euclises’ John Talley

[iSelect] You have the honorable position of being one of the leading medicinal chemists in the world. [John] It’s funny.  I don’t think of myself that way at all.  I’ve had the great fortune to work with really great people on really good projects. We worked on some... Read more

BioTech Selection Committee Member, Melissa Walker

Spotlight: Selection Committee Member A Chat with iSelect BioTech Selection Committee Member, Melissa Walker   A Brief Background: Melissa is a regulatory professional with over 27 years of experience in the medical products industry. She currently serves as... Read more
BioTech Selection Committee: Bobby Sandage

BioTech Selection Committee: Bobby Sandage

Spotlight: Selection Committee Member  A Brief Background: Bobby W. Sandage, Jr., Ph.D. has 34 years of experience in the pharmaceutical and biotech industry and was recently appointed President and CEO of Euclises Pharmaceuticals a St. Louis based start-up... Read more